GSWM
AVEO

Golden State Wealth Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Golden State Wealth Management’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-500
Closed -$3K – 377
2021
Q3 		$3K Buy
+500
New +$2.99K ﹤0.01% 305

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Golden State Wealth Management's AVEO Position: Q4 2021 in Review

Golden State Wealth Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2021, closing a stake of 500 shares — an estimated $3K sold.

Golden State Wealth Management first reported a position in AVEO in Q3 2021 and held it in 1 quarter. The position peaked at $3K in Q3 2021. 58 funds tracked by Wall St. Rank hold AVEO as of Q4 2021.

  • Golden State Wealth Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • Golden State Wealth Management sold 500 AVEO Pharmaceuticals, Inc. shares in Q4 2021, an estimated $3K.
  • Golden State Wealth Management first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2021 and held it in 1 quarter.
  • Golden State Wealth Management's AVEO Pharmaceuticals, Inc. position peaked at $3K in Q3 2021.
  • 58 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2021.

Based on Golden State Wealth Management's 13F filing for Q4 2021, filed 14 Feb 2022.